Provided by Tiger Trade Technology Pte. Ltd.

Verrica Pharmaceuticals Inc.

5.67
+0.06001.07%
Volume:71.94K
Turnover:408.64K
Market Cap:90.66M
PE:-1.92
High:5.93
Open:5.60
Low:5.50
Close:5.61
52wk High:9.82
52wk Low:3.28
Shares:15.99M
Float Shares:1.94M
Volume Ratio:0.50
T/O Rate:3.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9552
EPS(LYR):-14.7812
ROE:-1546.58%
ROA:-26.28%
PB:-5.32
PE(LYR):-0.38

Loading ...

Verrica Pharmaceuticals Names Chris Chapman Chief Commercial Officer

Reuters
·
Feb 12

Verrica Pharmaceuticals Appoints Chris Chapman as Chief Commercial Officer

THOMSON REUTERS
·
Feb 12

Verrica Pharmaceuticals Launches YCANTH in Japan with Torii Pharmaceutical

Reuters
·
Feb 09

Verrica Pharmaceuticals Announces Launch of Ycanth® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical

THOMSON REUTERS
·
Feb 09

Verrica Pharmaceuticals Files Initial Beneficial Ownership Statement for BKB Growth Investments

Reuters
·
Jan 27

BRIEF-Verrica Pharmaceuticals Announces First Patient Dosed In Phase 3 Program

Reuters
·
Jan 07

Verrica Pharmaceuticals Doses First Patient in Phase 3 Trial of YCANTH for Common Warts

Reuters
·
Jan 07

Verrica Pharmaceuticals Inc - Torii to Fund First $40 Mln of Phase 3 Trial Costs

THOMSON REUTERS
·
Jan 07

Verrica Pharmaceuticals Announces First Patient Dosed in Phase 3 Program Evaluating Ycanth® (Vp-102) for the Treatment of Common Warts

THOMSON REUTERS
·
Jan 07

Verrica Pharmaceuticals Files Initial Beneficial Ownership Statement for Director Charles Frantzreb

Reuters
·
Dec 30, 2025

Verrica Pharmaceuticals Grants New Equity Awards to Executives Under 2018 Plan

Reuters
·
Dec 30, 2025

Top Premarket Decliners

MT Newswires Live
·
Dec 16, 2025

Verrica Pharmaceuticals CMO Noah L. Rosenberg Acquires Common Shares

Reuters
·
Nov 26, 2025

Director and 10% Owner Paul B. Manning Reports Acquisition of Verrica Pharmaceuticals Inc. Common Shares

Reuters
·
Nov 26, 2025

Verrica Pharmaceuticals CEO Jayson Rieger Reports Acquisition of Common Shares

Reuters
·
Nov 26, 2025

Interim CFO John J. Kirby Acquires Common Shares of Verrica Pharmaceuticals Inc

Reuters
·
Nov 26, 2025

BRIEF-Verrica Pharmaceuticals Enters Securities Purchase Agreement With Institutional Investors

Reuters
·
Nov 25, 2025

Verrica Pharmaceuticals Inc - Enters Securities Purchase Agreement With Institutional Investors - SEC Filing

THOMSON REUTERS
·
Nov 25, 2025

Verrica Pharmaceuticals Inc - to Sell 6.5 Mln Shares in Private Placement - SEC Filing

THOMSON REUTERS
·
Nov 25, 2025

Verrica Pharmaceuticals Raises $50 Million in Private Placement Financing

Reuters
·
Nov 24, 2025